Investor FAQ

Where is the Company’s corporate headquarters?  

Our corporate headquarters are located at 40 Guest Street, Boston, MA 02135.

When was the Company founded?  

We were founded in December of 2014.

Where is the Company incorporated?  

Cue Biopharma was incorporated in December 2014 in Delaware.

When was the IPO? What was the price?  

Cue Biopharma announced its IPO on January 2nd, 2018 at a price of $7.50 per share.

What is the Company’s fiscal year?  

The Company’s fiscal year ends December 31st.

How is the stock traded?  

Our stock trades on The NASDAQ Capital Market under the ticker symbol “CUE.”

Who acts as the Company’s transfer agent? Can they help with changes of address and lost stock certificates?  

The transfer agent and registrar for the common stock of Cue Biopharma is Computershare.
Please contact them in the event of lost certificates or changes of address.

150 Royall Street
Canton, MA 02021
(800) 942-5909

Who is the Company’s auditor?  

Cue Biopharma’s auditor is RSM US LLP, located in Boston, Massachusetts.

Who is the Company’s legal counsel?  

Cue Biopharma’s legal counsel is WilmerHale, located in Boston, Massachusetts.

Where can I get the latest corporate news and financial reports?  

Our press release archive can be viewed under the “News” tab on our website and financial reports are available under the “Financial Information” section under the “Investors & Media” tab located on our website.

Where can I locate the Company’s SEC filings?  

Cue Biopharma’s SEC Filings can be found on and are also available under the “Financial Information” section under the “Investors & Media” tab located on our website.

Who is on the Executive Management team and Board of Directors?  

For a list of the Executive Management team and the Board of Directors please visit the “About Us” tab on our website.

Whom should I contact with investor inquiries?  

For investor inquiries, please contact:

Kerri-Ann Millar
Cue Biopharma